Gerard Meuchner

Bio:

Gerard K. Meuchner is the Head of Communications of Keenova Therapeutics plc, a U.S.-focused branded therapeutics company that strives to help patients with rare or unaddressed conditions live happier and healthier lives. He joined the company in October 2025.

Prior to Keenova, Gerard was the founder and president of gcomms.org, where he advised senior executives on brand messaging, storytelling, and reputation management. With more than three decades of experience, he has built a career translating complex issues into clear, compelling narratives. He has served twice as a Fortune 500 Chief Communications Officer—most recently at Henry Schein, where he built a global communications function for the world’s largest provider of healthcare products and services to office-based practitioners, and previously at Kodak, where he guided communications during the company’s historic transformation from film to digital.

Gerard was also a founding member of Bloomberg News and is passionate about helping leaders communicate with clarity and confidence in an increasingly distracted world.